Michael S. Wyzga - 09 Jun 2026 Form 4 Insider Report for Tvardi Therapeutics, Inc. (TVRD)

Reporting relationship: Director
Issuer ticker: TVRD
Reported as of: 09 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Jun 2026, 16:30:17 UTC
Prior SEC filing: 27 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Dan Conn, Attorney-in-Fact

Key filing fact

Michael S. Wyzga filed Form 4 for Tvardi Therapeutics, Inc. (TVRD) on 11 Jun 2026.

Key facts

This page summarizes Michael S. Wyzga's Form 4 filing for Tvardi Therapeutics, Inc. (TVRD).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 11 Jun 2026, 16:30.

Change

Previous filing in this sequence was filed on 27 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001201256 Primary reporting owner

WYZGA MICHAEL S

Relationship: Director
Address: C/O TVARDI THERAPEUTICS, INC., 3 SUGAR CREEK CTR BLVD, STE 525, SUGAR LAND
Signature: /s/ Dan Conn, Attorney-in-Fact
Signature date: 11 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TVRD transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +6,000
Change %
Price: $0.000000^*
Shares after: 6,000
Date: 09 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,000
Exercise price: $2.78
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

100% of the shares underlying the option shall vest on the earlier of June 9, 2027 or the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service through such vesting date.